Hunan Fangsheng Pharm Co Ltd (603998) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥95.63 Million ≈ $13.99 Million USD) by net assets (CN¥1.75 Billion ≈ $256.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hunan Fangsheng Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Hunan Fangsheng Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Hunan Fangsheng Pharm Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Hunan Fangsheng Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ningbo Techmation Co Ltd SHG:603015	-0.006x
Zhejiang Fuchunjiang Environmental Thermoelectric Co Ltd SHE:002479	0.032x
Beijing Career International Co Ltd SHE:300662	0.059x
Zhuhai Port Co Ltd SHE:000507	0.045x
Shenzhen Sea Star Technology SHE:002137	0.031x
Gifore Agricultural Machinery Chain Co Ltd SHE:300022	-0.017x
Shandong Shuangyi Technology Co Ltd SHE:300690	0.026x
Bright Minds Biosciences Inc NASDAQ:DRUG	-0.065x

Annual Cash Flow Conversion Efficiency for Hunan Fangsheng Pharm Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Fangsheng Pharm Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Hunan Fangsheng Pharm Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.73 Billion ≈ $253.87 Million	CN¥194.95 Million ≈ $28.53 Million	0.112x	+103.94%
2023-12-31	CN¥1.59 Billion ≈ $232.48 Million	CN¥87.54 Million ≈ $12.81 Million	0.055x	-72.45%
2022-12-31	CN¥1.51 Billion ≈ $220.66 Million	CN¥301.63 Million ≈ $44.14 Million	0.200x	+40.48%
2021-12-31	CN¥1.30 Billion ≈ $190.76 Million	CN¥185.63 Million ≈ $27.16 Million	0.142x	-23.85%
2020-12-31	CN¥1.27 Billion ≈ $185.22 Million	CN¥236.66 Million ≈ $34.63 Million	0.187x	+38.29%
2019-12-31	CN¥1.20 Billion ≈ $175.95 Million	CN¥162.58 Million ≈ $23.79 Million	0.135x	-14.54%
2018-12-31	CN¥1.11 Billion ≈ $162.84 Million	CN¥176.06 Million ≈ $25.76 Million	0.158x	+925.77%
2017-12-31	CN¥1.04 Billion ≈ $151.83 Million	CN¥16.00 Million ≈ $2.34 Million	0.015x	-87.27%
2016-12-31	CN¥979.69 Million ≈ $143.36 Million	CN¥118.70 Million ≈ $17.37 Million	0.121x	+24.64%
2015-12-31	CN¥931.73 Million ≈ $136.34 Million	CN¥90.57 Million ≈ $13.25 Million	0.097x	-13.08%
2014-12-31	CN¥841.94 Million ≈ $123.20 Million	CN¥94.16 Million ≈ $13.78 Million	0.112x	-64.82%
2013-12-31	CN¥386.85 Million ≈ $56.61 Million	CN¥122.97 Million ≈ $17.99 Million	0.318x	+318.63%
2012-12-31	CN¥318.83 Million ≈ $46.66 Million	CN¥24.21 Million ≈ $3.54 Million	0.076x	-69.88%
2011-12-31	CN¥258.49 Million ≈ $37.83 Million	CN¥65.16 Million ≈ $9.54 Million	0.252x	--

About Hunan Fangsheng Pharm Co Ltd

SHG:603998 China Drug Manufacturers - Specialty & Generic

Market Cap

$707.41 Million

CN¥4.83 Billion CNY

Market Cap Rank

#10865 Global

#3202 in China

Share Price

CN¥11.01

Change (1 day)

+0.18%

52-Week Range

CN¥9.57 - CN¥13.01

All Time High

CN¥18.09